In the BioHarmony Drug Report Database

"Preview" Icon

Ranolazine

Ranexa, Latixa (ranolazine) is a small molecule pharmaceutical. Ranolazine was first approved as Ranexa on 2006-01-27. It is used to treat angina pectoris in the USA. It has been approved in Europe to treat angina pectoris.

 

Trade Name

 

Latixa, Ranexa
 

Common Name

 

ranolazine
 

ChEMBL ID

 

CHEMBL1404
 

Indication

 

angina pectoris
 

Drug Class

 

Antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure

Image (chem structure or protein)

Ranolazine structure rendering